South Africa

south africa country outline

Estimated Number of Current PrEP Users

8,500-9,500

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

30,500-31,000

PEPFAR Target in COP 2018

18,826

Types of Delivery Projects

  • Clinical trials
  • Demonstration projects
  • Implementation projects
  • Large-scale implementation initiative
  • Open-label extension
  • Product introduction and support projects

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC are registered for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned projects in South Africa.

Policy Framework

Funding

NIAID, NIMH, NICHD, USAID, The Bill & Melinda Gates Foundation, PEPFAR, NIH, UNITAID, Anova Health Institute, Desmond Tutu HIV Foundation, Elton John AIDS Foundation, CAPRISA, DAIDS, IMPAACT Network, MSF, MTN, IPM, Nike Foundation, Wits RHI, London School of Hygiene & Tropical Medicine

Selected Technical & Strategic Assistance


Eligibility Criteria
Resources for South Africa
Glossary of Terms

Last updated September 30, 2018.

News Spotlight